You are here

Dato-DXd

5 FDA decisions to watch in the fourth quarter

BioPharma Dive

Wed, 10/2/24 - 11:24 am

Vertex Pharmaceuticals

PTC Therapeutics

Bristol Myers Squibb

AstraZeneca's experimental drug disappoints in breast cancer survival trial

Reuters

Mon, 09/23/24 - 11:29 am

clinical trials

5 FDA Decisions to Watch in the Second Half of 2024

BioSpace

Mon, 06/24/24 - 11:29 am

Alzheimer's disease

advanced synovial sarcoma

Lykos Therapeutics

Bristol Myers Squibb

non-small cell lung cancer

AZ, Daiichi Sankyo file Dato-DXd for second indication

Pharmaphorum

Tue, 04/2/24 - 11:31 am

13 Therapies Make Clarivate’s 2024 Drugs to Watch List

BioSpace

Wed, 01/10/24 - 06:30 pm

Tarpeyo/Kinpeygo

Daiichi Sankyo reports positive results from trial of breast cancer therapy

Clinical Trials Arena

Mon, 09/25/23 - 11:47 am

clinical trials

AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind

Fierce Biotech

Tue, 09/12/23 - 12:00 pm

antibody-drug conjugate

non-small cell lung cancer

AZ, Daiichi take aim at Gilead in triple-negative breast cancer

Pharmaforum

Wed, 12/8/21 - 10:37 am

Gilead Sciences

triple negative breast cancer